Definitive Contract HHSN268200736191C
Award Date 10/31/06
Potential Completion Date 3/31/16
Potential Value $3.6M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
18
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study - Birmingham Field Center. The $7,699,918.00 cost-no-fee contract has a period of performance through June 30, 2034 and does not have a set-aside designation. UAB is a prominent public research university with extensive capabilities in biomedical research, clinical...
- This is a $1,050,298.53 federal contract award to the University of Alabama at Birmingham (UAB) by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for Task Area B under the Coronary Artery Risk Development in Young Adults (CARDIA) program, with a period of performance from November 14, 2019, to October 31, 2021, and an ultimate completion date of January 31, 2023. UAB is the prime contractor for this cost-no-fee...
- This is a definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the University of Alabama at Birmingham (UAB) for research and development facilities. The contract has a ceiling value of $51,806,163.19 and a completion date of December 31, 2008. UAB, a public research university and academic medical center, has extensive experience in federal contracting and grants, particularly in areas such as cancer...
- This is a definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the Regents of the University of Michigan for the "Long Term Oxygen Treatment Trial" with a ceiling value of $2,882,600.31. The contract was awarded on October 31, 2006, with a final completion date of March 31, 2016. This contract was not set aside for any specific business type. Through past federal contracts and grants,...
- The University of Alabama at Birmingham (UAB) was awarded a $42,411,498.54 Definitive Contract by the National Institute of Allergy and Infectious Diseases (NIAID) Division of Extramural Activities (DEA) for biomedical research and services. This is a Cost No Fee contract with an ultimate completion date of December 1, 2013. UAB has a strong track record of securing federal funding for biomedical research, including grants from the National Institutes of Health (NIH). The contract does not...
- This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Pittsburgh, a non-profit educational institution, for the "Long Term Oxygen Treatment Trial". The definitive cost-no-fee contract has a ceiling value of $2,552,564.24 and a completion date of June 30, 2016. The contract does not have a set-aside designation. The University of Pittsburgh, a major recipient of federal research funding, is serving as the...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $72.0 million cost-no-fee definitive contract to the University of Alabama at Birmingham (UAB) on May 21, 2004, for operation of a field center supporting the Coronary Artery Risk Development in Young Adults (CARDIA) Study. This longitudinal epidemiological research initiative tracks cardiovascular risk factors and disease development in a cohort of young adults, with the Birmingham field center responsible for participant...
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham a delivery order valued at $771,759 to support the Coronary Artery Risk Development in Young Adults (CARDIA) Study Birmingham Field Center. This cost-no-fee delivery order, issued March 13, 2026, will operate through January 31, 2037, and is based at UAB's Birmingham, Alabama location. The contract carries no set-aside designation and reflects the institute's continued investment in the CARDIA Study,...
- This is a definitive federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the University of Alabama at Birmingham (UAB), a non-profit educational institution. The contract, valued at $1,687,776.46, is for other ADP and telecommunications services. The contract does not have a set-aside designation. UAB has a strong track record of securing federal contracts and grants, including work for the Department of Defense, NASA, and the...
- This federal contract award is for the Long Term Oxygen Treatment Trial, a research study funded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract, a Definitive Contract with cost-no-fee pricing, was awarded to The Johns Hopkins University, a private non-profit research university, on October 31, 2006, with a ceiling value of $15,824,931.90 and a completion date of April 30, 2017. The contract did not have a set-aside...